Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors
Jason L. Hornick(Merrimack Pharmaceuticals (United States)), Christine M. Lovly(Vanderbilt University)
Cited by 107
Related Papers
Mechanisms of receptor tyrosine kinase activation in cancer
|Molecular Cancer|2018|1.1k
Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials
|PLoS ONE|2012|203
Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting
|Nature Communications|2021|70
Validating Immunohistochemical Staining for KIT (CD117)
|American Journal of Clinical Pathology|2003|43
Allele-specific activation, enzyme kinetics, and inhibitor sensitivities of EGFR exon 19 deletion mutations in lung cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2022|3